专题:Lipoproteins and Cardiovascular Health

This cluster of papers focuses on the efficacy and safety of cholesterol-lowering treatments, particularly statins, in the prevention and management of cardiovascular diseases. It includes meta-analyses, clinical trials, guidelines, and genetic studies related to LDL cholesterol, atherosclerotic cardiovascular risk, hypercholesterolemia, and the role of C-reactive protein. The cluster also explores the impact of statins on various patient populations and their pleiotropic effects.
最新文献
High-intensity versus very-high-intensity statin, both on top of ezetimibe, in acute myocardial infarction: A pragmatic randomized study

article Full Text OpenAlex

Comment on “Evaluating the Effectiveness and Safety of Evinacumab in Treating Hypercholesterolemia and Hypertriglyceridemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials”

article Full Text OpenAlex

Sterol Regulatory Element-Binding Proteins and Metabolic Diseases: Mechanisms, Implications, and Therapeutic Strategies

article Full Text OpenAlex

Association of Clopidogrel Genetic Polymorphism With Efficacy and Safety for Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Updated Meta-Analysis

review Full Text OpenAlex

Clinical Obesity and All-Cause and Cause-Specific Mortality in UK Biobank

article Full Text OpenAlex

Ticagrelor-Induced Complete Heart Block

article Full Text OpenAlex

Challenges in achieving LDL-C goals: Insights from the Italian SANTORINI study cohort

article Full Text OpenAlex

Reduction of visit-to-visit LDL-C intraindividual variability in patients treated with PCSK9 inhibitors and inclisiran vs standard lipid-lowering therapy

article Full Text OpenAlex

Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease

article Full Text OpenAlex

The association between serum lipid levels and colorectal cancer risk: A dose-response meta-analysis of 23 studies

article Full Text OpenAlex

近5年高被引文献
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

article Full Text OpenAlex 1069 FWCI318.99567993

Pathophysiology of Atherosclerosis

review Full Text OpenAlex 781 FWCI91.40428063

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

article Full Text OpenAlex 732 FWCI367.22325421

The Role of Inflammation in Cardiovascular Disease

review Full Text OpenAlex 570 FWCI66.36848284

Stroke genetics informs drug discovery and risk prediction across ancestries

review Full Text OpenAlex 529 FWCI137.61370712

Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials

article Full Text OpenAlex 512 FWCI257.91262847

Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction

article Full Text OpenAlex 512 FWCI153.29934571

10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023

review Full Text OpenAlex 442 FWCI91.83330021

2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

article Full Text OpenAlex 440 FWCI131.22665885

Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease

article Full Text OpenAlex 427 FWCI127.59827197